Tenax Therapeutics, Inc.TENXNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank14
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-9.09
↑ 96% vs avg
Percentile
P14
Within normal range
Streak
3 yr
Consecutive declineElevated
Average
-252.23
Historical baseline
PeriodValueYoY Change
2025-9.09-69.2%
2024-5.37-660.1%
2023-0.71-139.0%
2022-0.30+55.1%
2021-0.66+52.9%
2020-1.40-34.6%
2019-1.04-300.2%
2018-0.26+100.0%
2017-2502.20-200336.2%
2016-1.25-